Last $191.36 USD
Change Today -1.57 / -0.81%
Volume 1.2M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard Bell M.D.

Co-Founder, Chairman of the Board and Chief Executive Officer, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
56$13,388,704
As of Fiscal Year 2013

Background*

Dr. Leonard Bell, M.D., Co-Founded Alexion Pharmaceuticals, Inc. and has been its Chief Executive Officer since January 1992 and Chairman of the Board since October 2014. Dr. Bell served as Secretary of Alexion Pharmaceuticals, Inc. since 1992 and as its Treasurer since January 1992. From January 1992 to March 2002, Dr. Bell also served as the President of Alexion Pharmaceuticals, Inc. He has been a Director of Alexion Pharmaceuticals, Inc., since February 1992. He serves ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

1992-Present
Co-Founder, Chairman of the Board and Chief Executive Officer
2000-N/A
Former Director

Education*

BA
Brown University
MD
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Salary$1,200,000
Total Annual Compensation$1,200,000

Stock Options*

Restricted Stock Awards$4,270,038
All Other Compensation$17,654
Exercised Options180,664
Exercised Options Value$21,844,933
Exercisable Options2,073,417
Exercisable Options Value$222,345,755
Unexercisable Options498,045
Unexercisable Options Value$30,768,616
Total Value of Options$274,959,304
Total Number of Options2,752,126

Total Compensation*

Total Annual Cash Compensation$3,617,654
Total Short Term Compensation$1,200,000
Other Long Term Compensation$4,287,692
Total Calculated Compensation$13,388,704
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $191.36 USD -1.57

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Stephen Foots Chief Executive Officer, Executive Director, Chairman of Group Executive Committee, Member of Risk Management Committee, Member of Routine Business Committee, Member of Nomination Committee, Member of Finance Committee and Member of Group Safety, Health & Environment Steering Committee
Croda International plc
535.0K GBP
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
€1.1M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.